Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.38 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.38 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.38 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.38 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3510151 | 1.00 | SLC1A1 (0.38) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL1373976 | 1.00 | SLC1A1 (0.38) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL21002223 | 0.87 | GSR (0.33) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL2723398 | 0.85 | SLC1A1 (0.51) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL29831114 | 0.82 | GRM8 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL22502695 | 0.82 | GRM8 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL5496875 | 0.82 | GRM8 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL167845 | 0.82 | ALOX15 (0.58) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL8697 | 0.82 | SLC1A1 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B | |
| SCHEMBL17724321 | 0.82 | SLC1A1 (0.60) | SLC1A1GRM8GRM6GRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 456 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118976052-A | Preparation method and application of polyphenol extract of fresh flavedo of flavedo | 江苏海洋大学 | 2024-11-19 | — | — | CN | claimed |
| CN-118874229-A | Separation membrane for delaying physical aging and preparation method and application thereof | 天津大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118638826-A | Application of surfactant or nano-disc in synthesizing membrane protein in cell-free synthesis system | 清华大学 | 2024-09-13 | — | — | CN | claimed |
| CN-118638764-A | Method for producing ACE2 using cell-free protein expression system and use of ACE2 | 清华大学 | 2024-09-13 | — | — | CN | claimed |
| CN-118165851-A | Additives for cell-free reaction systems, compositions and uses thereof | 清华大学 | 2024-06-11 | — | — | CN | claimed |
| CN-117942408-A | Inorganic nano-enzyme for catalyzing glutamic acid to convert ammonia, preparation method and application thereof in bone cancer pain treatment medicine | 复旦大学 | 2024-04-30 | — | — | CN | claimed |
| CN-117732092-A | High-efficiency low-energy-consumption amino acid evaporative crystallization equipment and process | 山东祥瑞药业有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-115531335-B | Oselta phosphate Wei Kou disintegrating tablet and preparation method thereof | 合肥医工医药股份有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117310064-A | Method for detecting 21 free amino acids in tea leaves | 西北农林科技大学 | 2023-12-29 | — | — | CN | claimed |
| US-20230417668-A1 | SURFACE PLASMON RESONANCE SIGNAL AMPLIFICATION | SWK FUNDING LLC | 2023-12-28 | — | — | US | claimed |
| US-20060058221-A1 | Baclofen conjugate and a pharmaceutical composition for treatment of neuronal disorders | MILLER LANDON C | 2006-03-16 | — | — | US | claimed |
| US-20050054580-A1 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells | NOVELOS THERAPEUTICS, INC. (US) | 2005-03-10 | — | — | US | claimed |
| EP-1131340-B1 | HEXAPEPTIDE WITH THE STABILIZED DISULFIDE BOND AND DERIVATIVES THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOSIS | NOVELOS THERAPEUTICS INC (US) | 2004-10-13 | — | — | EP | claimed |
| US-20030077334-A1 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanism for normal and transformed cells | KOZHEMYAKIN LEONID A (RU) | 2003-04-24 | — | — | US | claimed |
| CN-1371388-A | Hexapeptide with stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation differentiation and apoptosis | NOVILOSE MEDICAL CO (US) | 2002-09-25 | — | — | CN | claimed |
| US-20020016288-A1 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells | KOZHEMYAKIN LEONID A (RU) | 2002-02-07 | — | — | US | claimed |
| US-6312734-B1 | FORMING AN OXIDIZED GLUTATIONE COMPLEX WITH PLATINUM OR PALLADIUM | NOVELOS THERAPEUTICS, INC. | 2001-11-06 | — | — | US | claimed |
| EP-1131340-A2 | HEXAPEPTIDE WITH THE STABILIZED DISULFIDE BOND AND DERIVATIVES THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOSIS | Novelos Therapeutics, Inc. (US) | 2001-09-12 | — | — | EP | claimed |
| WO-2000031120-A2 | HEXAPEPTIDE WITH THE STABILIZED DISULFIDE BOND AND DERIVATIVES THEREOF REGULATING METABOLISM, PROLIFERATION, DIFFERENTIATION AND APOPTOSIS | NOVELOS THERAPEUTICS, INC. (US) | 2000-06-02 | — | — | WO | claimed |
| CN-1041159-A | Peptide compounds | HAFSLUND NYCOMED BIOREG (NO) | 1990-04-11 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016288-A1 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells | GPX4, GPX1, GSR | SLC1A1 1120/4885GRM8 803/4885GRM6 388/4885 |
| US-20030077334-A1 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanism for normal and transformed cells | GPX4, GPX1, GSR | SLC1A1 1119/4885GRM8 807/4885GRM6 392/4885 |
| US-20050054580-A1 | Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells | GPX4, GPX1, GSR | SLC1A1 1120/4885GRM8 803/4885GRM6 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.